Skip to main content
. 2022 Apr 20;97(7):877–884. doi: 10.1002/ajh.26566

FIGURE 1.

FIGURE 1

Overall survival of all patients and amyloidosis‐associated monoclonal gammopathy of renal significance (MGRS‐A) and non‐amyloidosis‐associated gammopathy of renal significance (MGRS‐NA). Overall survival of all patients with monoclonal gammopathy of renal significance (A) and overall survival of patients with MGRS‐A, and MGRS‐NA (B) [Color figure can be viewed at wileyonlinelibrary.com]